Alto Neuroscience, Inc.
ANRO
$3.43
$0.020.59%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 23.28M | 22.88M | 21.61M | 17.54M | 13.46M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 70.24M | 69.90M | 68.61M | 63.38M | 54.21M |
| Operating Income | -70.24M | -69.90M | -68.61M | -63.38M | -54.21M |
| Income Before Tax | -64.86M | -63.18M | -61.43M | -57.45M | -49.81M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -64.86 | -63.18 | -61.43 | -57.45 | -49.81 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -64.86M | -63.18M | -61.43M | -57.45M | -49.81M |
| EBIT | -70.24M | -69.90M | -68.61M | -63.38M | -54.21M |
| EBITDA | -69.61M | -69.32M | -68.11M | -62.93M | -53.83M |
| EPS Basic | -2.41 | -2.35 | -2.55 | -4.95 | -6.77 |
| Normalized Basic EPS | -1.49 | -1.45 | -1.59 | -3.10 | -4.23 |
| EPS Diluted | -2.41 | -2.35 | -2.55 | -4.95 | -6.77 |
| Normalized Diluted EPS | -1.49 | -1.45 | -1.59 | -3.10 | -4.23 |
| Average Basic Shares Outstanding | 107.85M | 107.70M | 98.25M | 75.25M | 52.03M |
| Average Diluted Shares Outstanding | 107.85M | 107.70M | 98.25M | 75.25M | 52.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |